The Beauty Health Company (SKIN) Proxy Filing summary

Executive summary

• Annual meeting scheduled for June 12, 2025, to be held virtually, with voting on three main proposals: election of seven directors, ratification of Deloitte & Touche LLP as auditor, and advisory approval of executive compensation.

• Shareholders can vote electronically, by phone, or by mail, and may revoke proxies before or during the meeting.

• Only holders of Class A Common Stock as of April 16, 2025, are eligible to vote, with each share entitled to one vote.

Voting matters and shareholder proposals

• Proposal 1: Election of seven director nominees for one-year terms; board recommends voting FOR all nominees.

• Proposal 2: Ratification of Deloitte & Touche LLP as independent auditor for fiscal 2025; board recommends FOR.

• Proposal 3: Advisory vote on executive compensation; board recommends FOR.

• Shareholder proposals for the 2026 meeting must be received by December 30, 2025.

Board of directors and corporate governance

• Board consists of seven members post-meeting, with diverse backgrounds in healthcare, finance, technology, and consumer products.

• Majority of directors are independent per Nasdaq and SEC standards.

• Board committees: Audit, Compensation, and Nominating & Corporate Governance, each with defined responsibilities and independent members.

• Annual board and committee self-evaluations and regular executive sessions without management.

• LCP Edge Holdco retains rights to designate directors based on ownership percentage.